Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Pharma Manufacturing Association Takes Steps To Snag Unethical Member Companies

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Amid stepped-up government surveillance of the local pharma industry, the Korea Pharmaceutical Manufacturers Association is opening what it calls a "distribution irregularity reporting center," in an effort to stop illegal deals among drug companies, hospitals and pharmacies

You may also be interested in...



Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said

Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said

Korea Pharmaceutical Manufacturers Association President Under Fire For Alleged Kickbacks

SEOUL - Four months after an aggressive declaration that his association would not tolerate any member company involvement in unethical or improper business deals with doctors and hospitals, the president of the Korea Pharmaceutical Manufacturers Association is under fire for his company's alleged kickbacks to doctors

Related Content

UsernamePublicRestriction

Register

SC070829

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel